The FDA issued a warning letter to Novo Nordisk for failing to report serious adverse events linked to Ozempic, Wegovy, and Saxenda. Investigators cited systemic failures in reporting strokes, suicides, and deaths.
The FDA issued a warning letter to Novo Nordisk for failing to report serious adverse events linked to Ozempic, Wegovy, and Saxenda. Investigators cited systemic failures in reporting strokes, suicides, and deaths.